The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,435.00
Bid: 1,454.00
Ask: 1,456.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.138%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,435.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Indivior director ups stake

Wed, 11th Aug 2021 16:08

(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.
Stejbach, who previously served as chief commercial officer at Alkermes, purchased the shares on Monday at an average price of 161.63p each, for a total value of £58,186.80.

Back in July, Indivior reiterated its upgraded guidance for 2021 and announced the start of a $100.0m share buyback programme after first-half net revenues rose from $303.0m to $381.0m.

As of 1640 BST, Indivior shares were up 1.74% at 164.0p.

Top Director Buys

Argentex Group (AGFX)
Director name: Beckwith,Henry
Amount purchased: 249,499 @ 80.00p
Value: £199,599.20

Argentex Group (AGFX)
Director name: Adams,Harry
Amount purchased: 133,750 @ 80.00p
Value: £107,000.00

Indivior (INDV)
Director name: Stejbach,Mark
Amount purchased: 36,000 @ 161.63p
Value: £58,186.80

Glaxosmithkline (GSK)
Director name: Barron ,Hal
Amount purchased: 2,282 @ $20.29
Value: $38,180.74

Argentex Group (AGFX)
Director name: Stent,Jo
Amount purchased: 37,500 @ 80.00p
Value: £30,000.00

Argentex Group (AGFX)
Director name: Railton,Nigel
Amount purchased: 37,500 @ 80.00p
Value: £30,000.00

Argentex Group (AGFX)
Director name: Jones,Digby
Amount purchased: 37,500 @ 80.00p
Value: £30,000.00

Argentex Group (AGFX)
Director name: Gray,Jonathan
Amount purchased: 25,000 @ 80.00p
Value: £20,000.00

Bluejay Mining (JAY)
Director name: Stensgaard,Bo Møller
Amount purchased: 135,000 @ 13.90p
Value: £18,765.00

Abrdn (ABDN)
Director name: Flint,Douglas J
Amount purchased: 4,039 @ 290.50p
Value: £11,733.17

Power Metal Resources (POW)
Director name: Bell,Andrew
Amount purchased: 520,814 @ 2.10p
Value: £10,911.05

Argentex Group (AGFX)
Director name: Wilson,Lena
Amount purchased: 12,500 @ 80.00p
Value: £10,000.00

Indivior (INDV)
Director name: Stejbach,Mark
Amount purchased: 5,424 @ 165.90p
Value: £8,998.42

Abrdn (ABDN)
Director name: Flint,Douglas J
Amount purchased: 2,800 @ 290.80p
Value: £8,142.32

Uls Technology (ULS)
Director name: Scott,Oliver Rupert Andrew
Amount purchased: 6,158 @ 74.39p
Value: £4,580.92

Schroder British Opportunities Trust (SBO)
Director name: OBE,Christopher Keljik,
Amount purchased: 2,833 @ 105.28p
Value: £2,982.58

Power Metal Resources (POW)
Director name: Bell,Andrew
Amount purchased: 79,186 @ 2.09p
Value: £1,658.15

Bp (BP.)
Director name: Auchincloss,Murray
Amount purchased: 123 @ 305.45p
Value: £375.70

Bp (BP.)
Director name: Looney,Bernard
Amount purchased: 102 @ 305.45p
Value: £311.56

Prudential (PRU)
Director name: Wells,Mike
Amount purchased: 14 @ 1,419.69p
Value: £198.76

Prudential (PRU)
Director name: FitzPatrick,Mark
Amount purchased: 13 @ 1,419.69p
Value: £184.56

Croda International (CRDA)
Director name: Brophy ,Tom
Amount purchased: 2 @ 8,768.00p
Value: £175.36

Croda International (CRDA)
Director name: Maiden,Jez K
Amount purchased: 2 @ 8,768.00p
Value: £175.36

M&g (MNG)
Director name: Bousfield,Clare
Amount purchased: 63 @ 239.00p
Value: £150.57

Sabre Insurance Group (SBRE)
Director name: Carter,Geoffrey Richard
Amount purchased: 66 @ 227.50p
Value: £150.15

Firstgroup (FGP)
Director name: Mangold,Ryan
Amount purchased: 166 @ 90.38p
Value: £150.03

Qinetiq Group (QQ.)
Director name: Wadey ,Steve
Amount purchased: 45 @ 332.78p
Value: £149.75

Qinetiq Group (QQ.)
Director name: Smith,David
Amount purchased: 45 @ 332.78p
Value: £149.75

Glaxosmithkline (GSK)
Director name: Walmsley,Emma
Amount purchased: 8 @ 1,447.32p
Value: £115.79

Croda International (CRDA)
Director name: Foots,Steve
Amount purchased: 1 @ 8,768.00p
Value: £87.68



Top Director Sells

London Stock Exchange Group (LSEG)
Director name: Schwimmer,David
Amount sold: 24,113 @ 7,867.60p
Value: £1,897,114.45

Cranswick (CWK)
Director name: Couch,Adam
Amount sold: 14,505 @ 4,022.00p
Value: £583,391.12

Cranswick (CWK)
Director name: Bottomley,Mark
Amount sold: 9,756 @ 4,022.00p
Value: £392,386.33

Cranswick (CWK)
Director name: Brisby ,Jim
Amount sold: 9,748 @ 4,020.00p
Value: £391,869.61

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

Friday 3 May 
Ashoka India Equity Investment Trust PLCGM re share issue
HSBC Holdings PLCAGM
Intercontinental Hotels Group PLCAGM
Mondi PLCAGM
More Acquisitions PLCAGM
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York.

Read more
25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares.

Read more
12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Mar 2024 20:04

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600.

Read more
7 Mar 2024 12:39

DIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 19:10

Indivior says US court draws line on multi-district Suboxone case

(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case.

Read more
29 Feb 2024 09:47

Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Read more
22 Feb 2024 16:53

LONDON MARKET CLOSE: European stocks boosted by ECB and Fed minutes

(Alliance News) - Stock prices in Europe closed higher on Thursday, on the back of minutes from the latest European Central Bank and US Federal Reserve meetings.

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.